Overall, these results suggest that through an ER-dependent mechanism, E2 may increase mitochondrial ROS production by repressing UCPs, which offers a new perspective on the understanding of why E2 is a risk factor for breast cancer. Here, ESR1 is linked to breast carcinoma.